SDB bank completed a Tier 2 capital investment from the Belgian Investment Company for Developing countries (BIO) recently. Effected via a debt capital instrument amounting to USD 8 million,the investment is expected to further strengthen the bank’s capital base.
BIO are pioneers in the area of making structural contributions through direct investments in private sector projects, towards the end of nurturing socio-economic growth. BIO placed their trust in the potential of the bank amidst a general economy-wide downswing, bolstering the loan book of SDB bank by USD 40 million through this capital infusion. The investment is set to support SDB bank’s future growth plans in a significant manner. Further, the USD-based currency facility of the investment not only benefits SDB bank but it will have a far-reaching impact on the local economy as well.
The improvement in SDB bank’s capital adequacy will directly benefit the bank in sustaining its balance sheet growth, while the funds generated through the investment facility will further support the bank’s already considerable lending activities for Small and Medium Scale Enterprises (SMEs). ‘Consistent investment efforts through reputed Development Finance Institutions like BIO will ensure that SDB bank’s credibility and subsequent credit rating improve, drawing greater investor interest and confidence in funding our continued growth plans,’ stated CEO Thilak Piyadigama.
The pattern of asset growth, digital expansion and innovation that took place in 2019 helps SDB attract investors of this stature. The addition of the mobile payment app UPay to its fold stands as a key highlight.
0 comments: